Hawkins CJ - Search Results

1

TRAIL causes deletions at the HPRT and TK1 loci of clonogenically competent cells.

Miles MA, Shekhar TM, Hall NE, Hawkins CJ. Miles MA, et al. Among authors: hawkins cj. Mutat Res. 2016 May;787:15-31. doi: 10.1016/j.mrfmmm.2016.02.006. Epub 2016 Feb 18. Mutat Res. 2016. PMID: 26943263

2

TRAIL and malignant glioma.

Hawkins CJ. Hawkins CJ. Vitam Horm. 2004;67:427-52. doi: 10.1016/S0083-6729(04)67022-1. Vitam Horm. 2004. PMID: 15110189 Review.

3

TRAIL treatment provokes mutations in surviving cells.

Lovric MM, Hawkins CJ. Lovric MM, et al. Among authors: hawkins cj. Oncogene. 2010 Sep 9;29(36):5048-60. doi: 10.1038/onc.2010.242. Epub 2010 Jul 19. Oncogene. 2010. PMID: 20639907 Free PMC article.

4

Yeast techniques for modeling drugs targeting Bcl-2 and caspase family members.

Beaumont TE, Shekhar TM, Kaur L, Pantaki-Eimany D, Kvansakul M, Hawkins CJ. Beaumont TE, et al. Among authors: hawkins cj. Cell Death Dis. 2013 May 2;4(5):e619. doi: 10.1038/cddis.2013.143. Cell Death Dis. 2013. PMID: 23640461 Free PMC article.

5

Inhibition of Bcl-2 or IAP proteins does not provoke mutations in surviving cells.

Shekhar TM, Green MM, Rayner DM, Miles MA, Cutts SM, Hawkins CJ. Shekhar TM, et al. Among authors: hawkins cj. Mutat Res. 2015 Jul;777:23-32. doi: 10.1016/j.mrfmmm.2015.04.005. Epub 2015 Apr 15. Mutat Res. 2015. PMID: 25916945

6

Data on the DNA damaging and mutagenic potential of the BH3-mimetics ABT-263/Navitoclax and TW-37.

Green MM, Shekhar TM, Hawkins CJ. Green MM, et al. Among authors: hawkins cj. Data Brief. 2016 Jan 16;6:710-4. doi: 10.1016/j.dib.2016.01.013. eCollection 2016 Mar. Data Brief. 2016. PMID: 26958630 Free PMC article.

7

IAP antagonists sensitize murine osteosarcoma cells to killing by TNFα.

Shekhar TM, Miles MA, Gupte A, Taylor S, Tascone B, Walkley CR, Hawkins CJ. Shekhar TM, et al. Among authors: hawkins cj. Oncotarget. 2016 Jun 7;7(23):33866-86. doi: 10.18632/oncotarget.8980. Oncotarget. 2016. PMID: 27129149 Free PMC article.

8

Old and Novel Functions of Caspase-2.

Miles MA, Kitevska-Ilioski T, Hawkins CJ. Miles MA, et al. Among authors: hawkins cj. Int Rev Cell Mol Biol. 2017;332:155-212. doi: 10.1016/bs.ircmb.2016.12.002. Epub 2017 Jan 27. Int Rev Cell Mol Biol. 2017. PMID: 28526132 Review.

9

Executioner caspases and CAD are essential for mutagenesis induced by TRAIL or vincristine.

Miles MA, Hawkins CJ. Miles MA, et al. Among authors: hawkins cj. Cell Death Dis. 2017 Oct 5;8(10):e3062. doi: 10.1038/cddis.2017.454. Cell Death Dis. 2017. PMID: 28981092 Free PMC article.

10

Pre-clinical evaluation of proteasome inhibitors for canine and human osteosarcoma.

Patatsos K, Shekhar TM, Hawkins CJ. Patatsos K, et al. Among authors: hawkins cj. Vet Comp Oncol. 2018 Dec;16(4):544-553. doi: 10.1111/vco.12413. Epub 2018 Jul 12. Vet Comp Oncol. 2018. PMID: 29998615

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters